172 related articles for article (PubMed ID: 31726354)
1. Development of a Microfluidic Culture Paradigm for Ex Vivo Maintenance of Human Glioblastoma Tissue: A New Glioblastoma Model?
Olubajo F; Achawal S; Greenman J
Transl Oncol; 2020 Jan; 13(1):1-10. PubMed ID: 31726354
[TBL] [Abstract][Full Text] [Related]
2. A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform.
Riley A; Green V; Cheah R; McKenzie G; Karsai L; England J; Greenman J
BMC Cancer; 2019 Mar; 19(1):259. PubMed ID: 30902086
[TBL] [Abstract][Full Text] [Related]
3. Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device.
Ma J; Li N; Wang Y; Wang L; Wei W; Shen L; Sun Y; Jiao Y; Chen W; Liu J
Biomed Microdevices; 2018 Sep; 20(3):80. PubMed ID: 30191323
[TBL] [Abstract][Full Text] [Related]
4. Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Lee JH; Lee JE; Kahng JY; Kim SH; Park JS; Yoon SJ; Um JY; Kim WK; Lee JK; Park J; Kim EH; Lee JH; Lee JH; Chung WS; Ju YS; Park SH; Chang JH; Kang SG; Lee JH
Nature; 2018 Aug; 560(7717):243-247. PubMed ID: 30069053
[TBL] [Abstract][Full Text] [Related]
5. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
Armocida D; Frati A; Salvati M; Santoro A; Pesce A
Clin Neurol Neurosurg; 2020 Nov; 198():106126. PubMed ID: 32861131
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of head and neck tumor on-chip: gateway to personalized treatment?
Bower R; Green VL; Kuvshinova E; Kuvshinov D; Karsai L; Crank ST; Stafford ND; Greenman J
Future Sci OA; 2017 Jun; 3(2):FSO174. PubMed ID: 28670466
[TBL] [Abstract][Full Text] [Related]
7. A microfluidic bubble perfusion device for brain slice culture.
Saleheen A; Acharyya D; Prosser RA; Baker CA
Anal Methods; 2021 Mar; 13(11):1364-1373. PubMed ID: 33644791
[TBL] [Abstract][Full Text] [Related]
8. Low co-expression of epidermal growth factor receptor and its chaperone heat shock protein 90 is associated with worse prognosis in primary glioblastoma, IDH-wild-type.
Sartori E; Langer R; Vassella E; Hewer E; Schucht P; Zlobec I; Berezowska S
Oncol Rep; 2017 Oct; 38(4):2394-2400. PubMed ID: 28765916
[TBL] [Abstract][Full Text] [Related]
9. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
[TBL] [Abstract][Full Text] [Related]
10. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
[TBL] [Abstract][Full Text] [Related]
11. A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens.
Kennedy R; Kuvshinov D; Sdrolia A; Kuvshinova E; Hilton K; Crank S; Beavis AW; Green V; Greenman J
Sci Rep; 2019 Apr; 9(1):6327. PubMed ID: 31004114
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Eur Radiol; 2018 Oct; 28(10):4350-4361. PubMed ID: 29721688
[TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
14. Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin.
Raghavan JV; Ganesh RA; Sonpatki P; Naik D; John AE; Arunachalam P; Shah D; P S H; Lakshmikantha A; Pillai S; Chandrachari KP; Mariswamappa K; Lale S; Shah N; Jhunjhunwala S
Oncoimmunology; 2021; 10(1):1957215. PubMed ID: 34377594
[TBL] [Abstract][Full Text] [Related]
15. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres.
Yoon SJ; Son HY; Shim JK; Moon JH; Kim EH; Chang JH; Teo WY; Kim SH; Park SW; Huh YM; Kang SG
J Transl Med; 2020 Dec; 18(1):482. PubMed ID: 33317554
[TBL] [Abstract][Full Text] [Related]
17. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
Roth P; Hottinger AF; Hundsberger T; Läubli H; Schucht P; Reinert M; Mamot C; Roelcke U; Pesce G; Hofer S; Weller M
Swiss Med Wkly; 2020 Jun; 150():w20256. PubMed ID: 32557428
[TBL] [Abstract][Full Text] [Related]
18. Head and Neck Squamous Cell Carcinoma Biopsies Maintained Ex Vivo on a Perfusion Device Show Gene Changes with Time and Clinically Relevant Doses of Irradiation.
Green V; Baldwin L; England J; Marshall G; Frost L; Moore C; Greenman J
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760543
[TBL] [Abstract][Full Text] [Related]
19. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic Lab-on-a-Chip Based on UHF-Dielectrophoresis for Stemness Phenotype Characterization and Discrimination among Glioblastoma Cells.
Lambert E; Manczak R; Barthout E; Saada S; Porcù E; Maule F; Bessette B; Viola G; Persano L; Dalmay C; Lalloué F; Pothier A
Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
